MTNB - Matinas BioPharma Holdings, Inc.
0.576
-0.028 -4.774%
Share volume: 8,648
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$0.60
-0.03
-0.05%
Summary score
5%
Profitability
0%
Dept financing
3%
Liquidity
50%
Performance
0%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-31.24%
Return on assets
-18.31%
Return on sales
0%
Return on invested capital
-115.44%
Total debt ratio
18.97%
Debt ratio change over timeo
0%
Current Ratio
9.81%
Quick Ratio
0%
Cash Position Ratio
6.6%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-11.07%
Return on assets
-9.82%
Return on sales
0%
Return on invested capital
-71.05%
Total debt ratio
12.19%
Debt ratio change over timeo
0%
Current Ratio
20.14%
Quick Ratio
0%
Cash Position Ratio
7.52%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-7.95%
Return on assets
-7.29%
Return on sales
0%
Return on invested capital
-77.48%
Total debt ratio
7.92%
Debt ratio change over time
0%
Current Ratio
28.74%
Quick Ratio
0%
Cash Position Ratio
6.27%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MTNB | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -31.24% | 17.45% | 4.69% | -3.05% |
| Return on assets | -18.31% | 3.37% | 3.35% | 3.6% |
| Return on sales | 0% | 23.96% | 25.96% | 32.14% |
| Return on invested capital | -115.44% | 5.2% | 4.37% | 5.09% |
| Profitability | 0% | 92% | 71% | 74% |
| Total debt ratio | 18.97% | 77% | 57.66% | 101.18% |
| Debt ratio change over time | 0% | 0% | 10.55% | 69.81% |
| Dept financing | 5% | 19% | 18% | 50% |
| Current Ratio | 20.14% | 1.16% | 1.27% | 2.08% |
| Quick Ratio | 0% | 0.89% | 1.01% | 1.96% |
| Cash Position Ratio | 7.52% | 0.17% | 0.53% | 1.48% |
| Liquididy | 50% | 24% | 31% | 32% |
| Short-term ratios | MTNB | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -11.07% | 44.06% | 6.24% | -25.62% |
| Return on assets | -9.82% | 3.88% | 3.22% | 3.26% |
| Return on sales | 0% | 27.04% | 24.93% | 31.22% |
| Return on invested capital | -71.05% | 9.69% | 4.96% | 8.14% |
| Profitability | 0% | 97% | 57% | 67% |
| Total debt ratio | 12.19% | 91.8% | 61.39% | 105.33% |
| Debt ratio change over time | 0% | 0% | 12.93% | 15.97% |
| Dept financing | 3% | 22% | 35% | 50% |
| Current Ratio | 20.14% | 1.16% | 1.27% | 2.08% |
| Quick Ratio | 0% | 0.89% | 1.01% | 1.96% |
| Cash Position Ratio | 7.52% | 0.17% | 0.53% | 1.48% |
| Liquididy | 50% | 13% | 16% | 33% |